Good Watch by 2030

Scientific Acceleration

AI agents run experiments and design molecules; discovery outpaces the institutions that approve and deploy it.

Probability this branch occurs by 2030
40–60%
4060%
1 revision · 0/2 tripwires crossed

The scenario

Autonomous research agents propose, run and analyse experiments in biology, chemistry and materials. Bottlenecks move from ideas to wet labs, clinical trials and regulators. The main risk is not the science but the same dual-use capability that the bio-misuse branch tracks.

Preconditions

  • Agents reliable on multi-week research tasks
  • Automated lab capacity
  • Regulators adapt trial and approval processes

Leading indicators

  • AI-attributed publications and patents
  • Automated lab investment
  • Regulatory pilot programs for AI-designed therapeutics

Tripwires

Observable thresholds. When one crosses, the scenario's status changes and the weekly re-run is brought forward.

clearsa-t1
A peer-reviewed discovery with an AI agent as the primary investigator
clearsa-t2
An AI-designed drug enters Phase III

Playbook

Prevent
  • Not applicable; manage the dual-use edge via the bio-misuse playbook.
Detect
  • Track publication and trial data.
Respond

individuals

  • Scientists: become the person who frames questions and validates; that role grows

organizations

  • Pharma and materials firms: automated labs and AI-native pipelines are the moat

governments

  • Regulator capacity is the bottleneck; fund it
  • Public funding for open scientific models so gains are not captured
Recover
  • Not applicable.
Steering signals · what moves probability toward this branch
  • Regulatory modernization
  • Open scientific datasets and models
  • Automated lab infrastructure funding

Probability history

Every change is logged with its reason and the signals that drove it. Moves are bounded per week; a jump beyond the bound is flagged as a shock.

Probability range over time
Your estimate

Disagree with our range? Set yours. Estimates feed a community view that appears once enough people weigh in, and the weekly run reads the gap between our number and yours.

50%
2026-09-16
40–60%
seed

Seed estimate, on watch: Terminal-Bench-Science jumped from 24.7% to 52.6% in one release; Amodei's "country of geniuses" framing has 90% by 2035.

Built on

Every source reviewed for this scenario. The full ledger is public.

DateSourcePublisherType
2026-09-01Claude Fable 5.1 and Mythos 5.1
Mythos limited to vetted users; Terminal-Bench 4.0 55.8/60.9%; OSWorld 2.0 77.9%.
Anthropicprimary
2026-02-13Dario Amodei on Dwarkesh Podcast
90% 'country of geniuses in a datacenter' by 2035; strong hunch 1–3 years.
Dwarkesh Podcaststatement